Sugar Land, TX, United States of America

Frank XiaoFeng Qin

This inventor holds 2 USPTO granted patents. Top assignee: Fantasia Biopharma (Zhejiang) Co. Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank XiaoFeng Qin. Retrieved from https://idiyas.com/inventor/frank-xiaofeng-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1


Location History:

  • Sugar Land Houston, TX (US) (2022)
  • Jiangsu, CN (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frank XiaoFeng Qin: Innovator in Oncolytic Virus Research

Introduction

Frank XiaoFeng Qin is a notable inventor based in Sugar Land, Houston, TX, who has made significant contributions to the fields of virology and cancer treatment. With two patents to his name, Qin's work focuses on innovative methods for harnessing modified viruses to combat tumors and enhance immune responses.

Latest Patents

Frank XiaoFeng Qin's latest patents include two groundbreaking inventions. The first patent involves "Attenuated Strains of Oncolytic Rhabdovirus and Uses Thereof in Tumor Treatment." This invention provides a modified matrix protein of a vesicular stomatitis virus, featuring specific amino acid substitutions, which has shown promise in developing drugs to kill abnormally proliferating cells and promote antitumor immune responses. The second patent is titled "Lentiviral Vector Capable of Directly Reflecting Type I Interferon Response, Preparation Method Thereof, and Applications Thereof." This patent outlines a method for creating a lentiviral vector system that accurately captures the type I interferon response, which is critical for understanding immune reactions in various conditions.

Career Highlights

Frank Qin currently works at Fantasia Biopharma (Zhejiang) Co., Ltd., a company known for its innovative approaches to biotechnology and pharmaceutical advancements. His career has been marked by a commitment to research that bridges the gap between virology and therapeutic applications, revealing new avenues in tumor treatment methodologies.

Collaborations

In his professional journey, Frank has collaborated with esteemed colleagues such as Jing Xia and Fei Wu. Together, they foster an environment of innovation and exploration, significantly contributing to advancements in their field.

Conclusion

Frank XiaoFeng Qin’s contributions to science through his patents demonstrate his dedication to improving cancer treatments and understanding viral behavior in a therapeutic context. His innovative work continues to pave the way for future research and developments in the medical field, showcasing the profound impact inventors can have on healthcare and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…